These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 491363)

  • 21. Cardioprotective effects of hydrolyzed bopindolol against contractile dysfunction produced by coronary stenosis and reperfusion in dogs.
    Noguchi K; Aniya Y; Ojiri Y; Chibana T; Matsuzaki T; Shiroma N; Fong KF; Uza M; Sakanashi M
    Arch Int Pharmacodyn Ther; 1994; 327(3):279-93. PubMed ID: 7848012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of the effect of different cardiovasotropic preparations on the contractility of separate sections of the myocardium in acute coronary occlusion].
    Kostin VI; Iakushev MP; Sapozhkov AV
    Farmakol Toksikol; 1985; 48(6):25-8. PubMed ID: 3936729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of nitroglycerin, digoxin and inderal of myocardial asynergy in ischemic heart disease].
    Shevchenko OP; Gasilin VS
    Kardiologiia; 1978 Sep; 18(9):84-9. PubMed ID: 100646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polycardiographic and ergometric studies after administration of atenolol and propranolol].
    Adamska-Dyniewska H; Pruszczyński J; Trela R
    Wiad Lek; 1982 Nov; 35(21):1311-6. PubMed ID: 6761976
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of mannitol to obviate propranolol-induced myocardial depression in ischemic canine heart.
    Kyriakidis G; Barletta M
    J Pharm Sci; 1980 Apr; 69(4):447-51. PubMed ID: 6768876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of anti-anginal therapy on the functional state of the myocardium in patients with chronic ischemic heart disease].
    Adamian KG; Asatrian MA; Oganesian LS; Grigorian NKh; Akopian BR
    Kardiologiia; 1985 Sep; 25(9):52-5. PubMed ID: 3935848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanisms of the anti-anginal effect of obzidan].
    Furkalo NK; Zaĭtseva VI
    Kardiologiia; 1984 Jun; 24(6):73-6. PubMed ID: 6748496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of propranolol on circulatory hemodynamics of patients with coronary heart failure in the light of polycardiographic examination.
    Mazurowa A; Tracz W
    Pol Med J; 1970; 9(4):827-34. PubMed ID: 5477489
    [No Abstract]   [Full Text] [Related]  

  • 29. [Stimulators of beta-adrenergic structures in treatment of ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Abinder AA; Iankin VV; Kitaeva IT
    Kardiologiia; 1975 Jul; 15(7):37-43. PubMed ID: 1568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the alpha and beta blocking effects of intravenous labetalol on left ventricular function in coronary artery disease.
    Gagnon RM; Presant S; Morissette M
    Can J Cardiol; 1985; 1(4):259-62. PubMed ID: 2996729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical use of propranolol (Inderal)].
    Doshchitsin VL; Zharov EI; Arshakuni RO
    Kardiologiia; 1967 Oct; 7(10):59-67. PubMed ID: 4179686
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
    Nikolenko SA; Metelitsa VI; Nazarenko VA; Martsevich SIu; Kulikova TV
    Kardiologiia; 1984 Feb; 24(2):14-8. PubMed ID: 6143849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of intrinsic sympathomimetic activity on regional left ventricular function; use of regional ejection fraction to demonstrate a beneficial action by pindolol over propranolol on hypokinetic segments.
    Johnston DL; Manyari DE; Kostuk WJ
    Can J Cardiol; 1985; 1(3):174-9. PubMed ID: 2996726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on mechanisms of diltiazem-induced protection of the ischemic myocardium: selective myocardial depressant action of diltiazem on an ischemic isolated blood-perfused canine papillary muscle preparation.
    Ngai JH; Yabuuchi Y; Schwartz A; Millard RW
    J Pharmacol Exp Ther; 1983 May; 225(2):462-9. PubMed ID: 6842404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Participation of the vasodilating property of nipradilol in improving ischemic derangement of myocardial energy metabolism.
    Higuchi M
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):157-65. PubMed ID: 2475707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of the inotropic action of nonachlazine].
    Kaverina NV; Katsenovich RA; Tkachenko BI; Iunusov ZZ; Ovsiannikov VI
    Farmakol Toksikol; 1985; 48(1):23-7. PubMed ID: 3979531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of specific bradycardic agents on exercise-induced regional myocardial dysfunction in dogs.
    Raberger G; Krumpl G; Schneider W; Mayer N
    Eur Heart J; 1987 Dec; 8 Suppl L():53-9. PubMed ID: 3451883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correction of extracardiac effects on the heart as a method of treating ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Litvitskiĭ PF; Bragina GI
    Farmakol Toksikol; 1982; 45(3):53-9. PubMed ID: 6284550
    [No Abstract]   [Full Text] [Related]  

  • 39. [Presystolic change in the length of the ischemic, border and distant myocardial areas in experimental coronary insufficiency and the action of inderal and metacin].
    Bykov II; Beliakov KF; Slobodin AK
    Kardiologiia; 1979 Apr; 19(4):98-102. PubMed ID: 439615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of long-term administration of propranolol to patients with ischemic heart disease].
    Bychko MV
    Lik Sprava; 2003; (5-6):93-5. PubMed ID: 14618816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.